|
New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) Clinical research trials and New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus). New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) clinical trial. Subjects frequently obtain the most expert healthcare possible for their New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus) condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus)  New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus)
New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus)
For Condition: Bacterial Infections,Drug Resistance, Microbial
Status: Recruiting
Sponsor(s): Pfizer ,
Synopsis: This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: /17 Years
Genders: Both
Protocol Entry Criteria: Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: - Hospitalized/chronic care pediatric patients (birth through 17 years) - Known infections due to vancomycin-resistant entercoccus species, including diagnosis of hospital-acquired pneumonia, complicated skin and skin structure infections, catheter-related bacteremia, bacteremia of unidentified source, and other infections - Requires a minimum of 3 days of IV medication - Patients with mixed infections due to VRE & gram negative bacteria are allowed to enroll in the study. For most of the infections, 2 or more of additional symptoms are required. Exclusion Criteria: - Potentially effective concomitant antibiotic - A high surgical cure rate - Medical conditions which would preclude clinical evaluation or require treatment of longer duration than 28 days - 24 hours of antibiotic treatment within 48 hours of study entry (unless pre-approved) - Having an infected device that could not be removed
Total Enrollment:
Location and Contact Information:
Research Center *Recruiting*
Chicago, Illinois, 60614
United States
Recruiting
Research Center *No longer recruiting*
Camden, New Jersey, 08103
United States
No longer recruiting
Research Center *Recruiting*
Austin, Texas, 78701
United States
Recruiting
Research Center *Recruiting*
Washington D.C., District of Columbia, 20010
United States
Recruiting
Research Center *No longer recruiting*
Gainesville, Florida, 32610
United States
No longer recruiting
Research Center *Recruiting*
Long Beach, California, 90806
United States
Recruiting
Research Center *Recruiting*
Detroit, Michigan, 48201
United States
Recruiting
Research Center *Recruiting*
New York City, New York, 10021
United States
Recruiting
Research Center *Terminated*
Gainesville, Florida, 32610
United States
Terminated
Research Center *Not yet recruiting*
Los Angeles, California, 90027
United States
Not yet recruiting
Research Center *Recruiting*
Atlanta, Georgia, 30342
United States
Recruiting
Research Center *Recruiting*
Philadelphia, Pennsylvania, 19104
United States
Recruiting
Research Center *Recruiting*
Baltimore, Maryland, 21287
United States
Recruiting
Research Center *No longer recruiting*
Louisville, Kentucky, 40202
United States
No longer recruiting
Research Center *Terminated*
Danville, Pennsylvania, 17822
United States
Terminated
Research Center *Recruiting*
New York City, New York, 10032
United States
Recruiting
Research Center *Recruiting*
Boston, Massachusetts, 02111
United States
Recruiting
Research Center *Recruiting*
Cleveland, Ohio, 44195
United States
Recruiting
Research Center *No longer recruiting*
New York City, New York, 10029
United States
No longer recruiting
Research Center *Recruiting*
Park Ridge, Illinois, 60068
United States
Recruiting
Research Center *Recruiting*
Los Angeles, California, 90095
United States
Recruiting
Research Center *Recruiting*
Hartford, Connecticut, 06106
United States
Recruiting
Additional Information:
Study ID Numbers: M/1260/0082-VRE;
Study Start Date:
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035854
Other Bacterial Infections Studies:
1. A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
2. Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
3. Antibiotic treatment for patients with infections of short term in-dwelling vascular catheters due to a specific bacteria (gram positive bacteria)
4. New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus)
5. A Study of Azithromycin in HIV-Infected Patients
Related Studies:
Other Bacterial Infections Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials
New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus)
|
|
|
|
|
|
|
|
